| Phase I Single Ascending Dose and Multiple Ascending Doses of Oral AFA-281 in Healthy Volunteers (NCT05547503) | Afasci Inc | 2023-04-11 |
| Modified Huang-Lian-Jie-Du Decoction (MHLJDD) for Atopic Dermatitis in Children (NCT05613062) | Chinese University of Hong Kong | 2023-04-11 |
| A Study in People With Overweight or Obesity to Test How Well Different Doses of BI 1820237 Are Tolerated When Given Alone or in Combination With Either Semaglutide or BI 456906 (NCT05751226) | Boehringer Ingelheim | 2023-04-11 |
| Evaluation of Basal Insulin Initialization and Titration in People With Type 2 Diabetes Wearing a Dexcom G6 Sensor (NCT07681375) | DexCom, Inc. | 2023-04-11 |
| Safety and Efficacy of Anti-GPRC5D CAR-T Cells Therapy in the Treatment of r/r MM (NCT05749133) | XuYan | 2023-04-10 |
| Comparative PK, Safety, Tolerability, Immunogenicity, and PD Profile Study of TUR03 and Soliris in Healthy Participants (NCT05863442) | Turgut Ardika PTY LTD | 2023-04-10 |
| Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cells (IxCell hUC-MSC-S) in the Treatment of Ischemic Stroke (NCT05697718) | Shanghai IxCell Biotechnology Co., LTD | 2023-04-10 |
| A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986325 in Healthy Japanese Participants (NCT05813717) | Bristol-Myers Squibb | 2023-04-10 |
| Palliadelic Treatment to Reduce Psychological Distress in Persons With Advanced Gastrointestinal Cancers (NCT05220046) | University of Nebraska | 2023-04-10 |
| Hutrukin to Analyze Safety and PK in Healthy Volunteers (NCT05098080) | XBiotech, Inc. | 2023-04-10 |
| Study of SGR-1505 in Mature B-Cell Neoplasms (NCT05544019) | Schrödinger, Inc. | 2023-04-10 |
| Effect of the Use of Self-Assembling Peptides Versus Resin Infiltration on Post Orthodontic White Spot Lesions: A Randomized Clinical Trial (NCT07773714) | Suez Canal University | 2023-04-10 |
| Clinical Trial to Evaluate the Safety and Immunogenicity of Synthetic DNAs Encoding NP-GT8 and IL-12, With or Without a TLR-agonist-Adjuvanted HIV Env Trimer 4571 Boost, in Adults Without HIV (NCT05781542) | National Institute of Allergy and Infectious Diseases (NIAID) | 2023-04-10 |
| Phase I Clinical Study of ZL-82 Tablets (NCT06055023) | Chengdu Zenitar Biomedical Technology Co., Ltd | 2023-04-09 |
| A Safety, Tolerability and Pharmacokinetics Study of Topical Ointment YR001 in Adult Healthy Volunteers (NCT05718921) | Hangzhou Yirui Pharmaceutical Technology Co., Ltd | 2023-04-08 |
| A Study to Evaluate the Pharmacokinetics and Safety of Azvudine Tablets in Healthy Adult Subjects and Healthy Elderly Subjects (NCT06991634) | Henan Genuine Biotech Co., Ltd. | 2023-04-08 |
| Safety and Pharmacokinetics of SIM0417 Combined With Ritonavir in Healthy Elderly Subjects (NCT05826249) | Jiangsu Simcere Pharmaceutical Co., Ltd. | 2023-04-07 |
| Safety and Efficacy of CELZ-201 in Patients With Recent Onset Type 1 Diabetes (NCT05626712) | Creative Medical Technology Holdings Inc | 2023-04-07 |
| Abemaciclib Neuropharmacokinetics of Diffuse Midline Glioma Using Intratumoral Microdialysis (NCT05413304) | National Cancer Institute (NCI) | 2023-04-07 |
| A Study of the Tolerance, Safety, and Pharmacokinetics of GNR-055 in Healthy Volunteers (NCT06475404) | AO GENERIUM | 2023-04-06 |
| Phase I Study of SHR-A2102 in Patients With Advanced Solid Tumors (NCT05701709) | Shanghai Hengrui Pharmaceutical Co., Ltd. | 2023-04-06 |
| Assessment of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ATH-063 in Healthy Subjects (NCT05807971) | Athos Therapeutics Inc | 2023-04-06 |
| Novel Approach to Increase EPA and DHA Levels (NCT07304921) | Riga Stradins University | 2023-04-06 |
| A Study to Assess the Safety and Pharmacokinetics of GDC-8264 in Combination With Standard of Care in Participants With Acute Graft-Versus-Host Disease (aGVHD) (NCT05673876) | Genentech, Inc. | 2023-04-06 |
| A Study of DP303c in Patients With HER2-positive Advanced Solid Tumors (NCT05810103) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2023-04-06 |
| A Study to Evaluate the Drug-drug Interactions (DDIs) of IBI362 With Metformin, Warfarin, Atorvastatin, Digoxin in Overweight or Obese Subjects (NCT05815680) | Innovent Biologics (Suzhou) Co. Ltd. | 2023-04-06 |
| A Clinical Trial of TG6050 in Patients With Metastatic Non-Small Cell Lung Cancer (Delivir) (NCT05788926) | Transgene | 2023-04-05 |
| Quantitative Fluorescence Endoscopy Using Durvalumab-680LT in Esophageal Cancer (NCT05450484) | University Medical Center Groningen | 2023-04-05 |
| A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1195, in 18- to 55-Year-Old Healthy Participants (NCT05831111) | ModernaTX, Inc. | 2023-04-05 |
| ADI-PEG 20 in Combination With Gemcitabine and Docetaxel After Progression on Frontline Therapy in Non-small Cell and Small Cell Lung Cancers (NCT05616624) | Washington University School of Medicine | 2023-04-05 |
| A Study to Evaluate the Drug-drug Interaction and Safety of RLD2301 and RLD2007 in Healthy Volunteers (NCT05862090) | Hanmi Pharmaceutical Company Limited | 2023-04-05 |
| A Clinical Trial to Evaluate the Safety and Immunogenicity of Synthetic DNAs Encoding a Native-like HIV Env Trimer and Interleukin-12 (INO-6160), Alone or in a Prime-boost Regimen With 3M-052-AF + Alum Adjuvanted VRC HIV Env Trimer 4571 in Adult Participants Without HIV (NCT05828095) | National Institute of Allergy and Infectious Diseases (NIAID) | 2023-04-05 |
| Study of VIP152, Venetoclax, and Prednisone (VVIP) in Relapsed/Refractory Lymphoid Malignancies (NCT05371054) | National Cancer Institute (NCI) | 2023-04-05 |
| A Research Study Looking at How a Single Dose of the Medicine Cagrilintide Works in Participants With Reduced Liver Function and in Healthy Participants With Normal Liver Function and How Cagrilintide is Absorbed and Used by the Body (NCT05564104) | Novo Nordisk A/S | 2023-04-05 |
| A Study to Learn How Different Amounts of the Study Medicine Called PF-07328948 Are Tolerated and Act in the Body in Healthy Adults (NCT05807490) | Pfizer | 2023-04-05 |
| A Study to Evaluate the Safety and Immunogenicity of a Single Dose of H1ssF-3928 mRNA-LNP in Healthy Adults (NCT05755620) | National Institute of Allergy and Infectious Diseases (NIAID) | 2023-04-05 |
| A First-in-human Study of IBI354 in Subjects with Locally Advanced Unresectable or Metastatic Solid Tumors (NCT05636215) | Innovent Biologics (Suzhou) Co. Ltd. | 2023-04-04 |
| Mutant CALR-peptide Based Vaccine in Patients With Mutated CALR Myeloproliferative Neoplasm (NCT05025488) | Marina Kremyanskaya | 2023-04-04 |
| Evaluation of Revumenib in Participants With Colorectal Cancer and Other Solid Tumors (NCT05731947) | Syndax Pharmaceuticals | 2023-04-04 |
| A Study to Investigate the Safety and Tolerability of Intravenous QEQ278 in Patients With Advanced Solid Tumors (NCT05462873) | Novartis Pharmaceuticals | 2023-04-04 |
| Phase 1/2 Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) (NCT05747924) | Avidity Biosciences, Inc. | 2023-04-04 |
| Effects of the Adjunctive Use of Hyaluronic Acid-based Gel in the Surgical Periodontal Treatment of Periodontitis (NCT06842511) | Ordu University | 2023-04-04 |
| Study of DISC-0974 to Assess the Safety, Tolerability, PK and PD of DISC-0974 in Participants With CKD and Anemia (NCT05745883) | Disc Medicine, Inc | 2023-04-04 |
| Study to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Receiving Oral ABBV-525 Tablets (NCT05618028) | AbbVie | 2023-04-04 |
| Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia and Myelodysplastic Syndrome/MPN Overlap Neoplasms (NCT05549661) | Mayo Clinic | 2023-04-04 |
| Targeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i) (NCT05521984) | Washington University School of Medicine | 2023-04-03 |
| RMC-5552 Monotherapy in Adult Subjects With Recurrent Glioblastoma (NCT05557292) | Nicholas Butowski | 2023-04-03 |
| Comparative Pharmacokinetic (PK) Study of Ibuprofen and Diphenhydramine Hydrochloride MR Tablets in Healthy Adults Under Fasting Condition (NCT05729555) | Overseas Pharmaceuticals, Ltd. | 2023-04-03 |
| Personalized TCR-T: Study of Adoptively Transferred T-cell Receptor Gene-engineered T Cells (TCR-T) (NCT05349890) | Providence Health & Services | 2023-04-03 |
| Study of HBV Therapeutic Vaccines GS-2829 and GS-6779 in Healthy Participants and Participants With Chronic Hepatitis B (NCT05770895) | Gilead Sciences | 2023-04-03 |
| Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors (NCT05704985) | DEKA Biosciences | 2023-04-03 |
| A Research Study Looking at Similarity Between Tirzepatide Versions for Different Injection Devices (NCT05810597) | Eli Lilly and Company | 2023-04-03 |
| Study of RiMO-301 and Radiotherapy With PD-1 Inhibitor for the Treatment of Head-Neck Cancer (NCT05838729) | Coordination Pharmaceuticals, Inc. | 2023-04-03 |
| Regulatory T Cells for Amyotrophic Lateral Sclerosis (NCT05695521) | Cellenkos, Inc. | 2023-04-03 |
| A Study to Test Experimental Blood Stage Malaria Vaccine in Burkina Faso. (NCT05790889) | University of Oxford | 2023-04-03 |
| Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors (NCT05856981) | Sairopa B.V. | 2023-04-03 |
| Green (Sustainable) VENTOLIN - Pharmacokinetics (PK) Study in Healthy Participants (NCT05791565) | GlaxoSmithKline | 2023-04-03 |
| A Study to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body, How it Moves Into, Through and Out of the Body When Single and Multiple Amounts Are Taken as Tablets in Japanese Healthy Male Participants (NCT05800444) | Bayer | 2023-04-03 |
| Single-dose, Two-way Crossover Bioequivalence of Lamotrigine in Healthy Male Volunteers Under Fasting Conditions (NCT06199791) | Desitin Arzneimittel GmbH | 2023-04-03 |
| CAR-DC Vaccine and ICIs in Local Advanced/Metastatic Solid Tumors (NCT05631899) | Chinese PLA General Hospital | 2023-04-03 |
| A Study of IMC008 for Advanced Solid Tumors (NCT05837299) | Changhai Hospital | 2023-04-02 |
| Recommended Dose Estimation of BP-C2 (NCT04186585) | Meddoc | 2023-04-01 |
| Pilot Study of Radiation-Induced Xerostomia Treatment With Allogeneic Mesenchymal Stromal Stem Cells (NCT07431645) | Institute of Oncology Ljubljana | 2023-04-01 |
| First in Human Study of TLC-ART 101 (ACTU 2001) (NCT05850728) | University of Washington | 2023-04-01 |
| The Effect of Platelet Rich Plasma for the Treatment of Osteochondral Lesions of the Talus (NCT05795660) | Ministry of Health, Kuwait | 2023-04-01 |
| A Phase Ⅰb/Ⅱ Clinical Study of SHR-A1811 Combined With Other Therapies in Patients With HER2 Low Advanced or Metastatic Breast Cancer. (NCT05792410) | Jiangsu HengRui Medicine Co., Ltd. | 2023-04-01 |
| Tranexamic Acid in Rhinoplasty: Perioperative Bleeding, Edema and Ecchymosis (NCT05774717) | Vanderbilt University Medical Center | 2023-04-01 |
| Loncastuximab Tesirine in Combination With Chemotherapy Prior to Stem Cell Transplant for the Treatment of Recurrent or Refractory Diffuse Large B-Cell Lymphoma (NCT05228249) | Fred Hutchinson Cancer Center | 2023-04-01 |
| Comparison Between MR Arthrography ,ct Arthrography and Conventional MR in Osteoachondral Lesions of Knee Osteo Arthritis (NCT05764603) | Assiut University | 2023-04-01 |
| A Clinical Trial to Access Pharmacokinetic Profiles and Safety of IVL3003. (NCT05345509) | Inventage Lab., Inc. | 2023-04-01 |
| Efficacy of Neoadjuvant Endocrine Therapy Compared to Chemotherapy in Breast Cancer Patients (NCT05755581) | Sohag University | 2023-04-01 |
| Safety and Efficacy of Venetoclax in Combination With Azacitidine and HA Regimen in the Treatment of AML in the Elderly (NCT05949762) | ZePing Zhou | 2023-04-01 |
| A Study of KM501 in Patients With Solid Tumors (NCT05804864) | Xuanzhu Biopharmaceutical Co., Ltd. | 2023-04-01 |
| Preventing Preterm Birth With a Negative Pressure Cervical Cup: a Feasibility Study (NCT05512052) | Galena Innovations, LLC | 2023-04-01 |
| 131I-TLX-101 for Treatment of Newly Diagnosed Glioblastoma (IPAX-2) (NCT05450744) | Telix Pharmaceuticals (Innovations) Pty Limited | 2023-04-01 |
| Ovarian Stimulation With FSH Alone Versus FSH Plus GnRH Antagonist in an Oocyte Donor/Recipient Programme (NCT05759871) | National and Kapodistrian University of Athens | 2023-04-01 |
| An Open Label, Balanced, Randomized, Two-Treatment, Two-Period, Two-Sequence, Two-way Crossover, Oralcomparative Pharmacokinetic（PK）Study of Lacosamide Extended-Release Tablets , Adult, Human Subjects Under Fasting Conditions. (NCT05788159) | Overseas Pharmaceuticals, Ltd. | 2023-04-01 |
| A Study on the Efficacy and Safety of Venetoclax Combined With HAA Regimen in Newly Diagnosed Young AML. (NCT05893472) | ZePing Zhou | 2023-04-01 |
| MSLN-targeted CAR-T Cells in Solid Tumors. (NCT05783089) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2023-04-01 |
| Surufatinib Combined With Tislelizumab in the Second-line and Further Treatment of Triple-negative Breast Cancer (NCT05746728) | Huihua Xiong | 2023-04-01 |
| A Study Evaluating the Efficacy of the Vielight Neuro RX Gamma in the Treatment of Post COVID-19 Cognitive Impairment (NCT05857124) | Vielight Inc. | 2023-04-01 |
| A Study of KM602 in Patients With Advanced Solid Tumors (NCT05766527) | Xuanzhu Biopharmaceutical Co., Ltd. | 2023-04-01 |
| A Clinical Trial of ALE.F02 in Patients With Advanced Liver Fibrosis and/or With Mild Cirrhosis (NCT05939947) | Alentis Therapeutics AG | 2023-04-01 |
| Ischemic Post-conditioning in Acute Ischemic Stroke Thrombectomy (PROTECT-1b) (NCT05909982) | Capital Medical University | 2023-04-01 |
| A Study of JS009 Monotherapy and JS009 as a Triple Combination Therapy in Patients With Advanced Malignancies (NCT05650203) | Shanghai Junshi Bioscience Co., Ltd. | 2023-03-31 |
| EUS RFA for Treatment of Pancreatic Ductal Adenocarcinoma (PDAC) (NCT05723107) | NYU Langone Health | 2023-03-31 |
| Safety and Preliminary Signs of Efficacy of F8IL10 for Intra-articular Treatment (NCT05622175) | Philogen S.p.A. | 2023-03-31 |
| A Trial to Evaluate the Effect of C21 on Endothelial Dysfunction in Subjects With Type 2 Diabetes (NCT05831644) | Vicore Pharma AB | 2023-03-31 |
| Virtual Reality Cognitive Therapy for Alzheimer's Disease (NCT05788848) | Claritytek, Inc. | 2023-03-31 |
| Testing the Addition of the AKT Inhibitor, Ipatasertib, to Treatment With the Hormonal Agent Megestrol Acetate for Recurrent or Metastatic Endometrial Cancers (NCT05538897) | National Cancer Institute (NCI) | 2023-03-31 |
| A Study to Evaluate the Safety, Tolerability, and Drug Levels of Danicamtiv in Healthy Japanese and Caucasian Participants (NCT05806359) | Bristol-Myers Squibb | 2023-03-31 |
| Venetoclax to Augment Epigenetic Modification and Chemotherapy (NCT05317403) | Medical College of Wisconsin | 2023-03-31 |
| Study to Assess the Safety and Pharmacokinetics of ATL-001 (Ciclopirox Olamine) in Healthy Volunteers (NCT05647343) | Atlas Molecular Pharma | 2023-03-31 |
| A Trial to Evaluate EP-104GI in Adults With Eosinophilic Esophagitis (EoE). (NCT05608681) | Eupraxia Pharmaceuticals Inc. | 2023-03-31 |
| Second Window Indocyanine Green for All Nervous System Tumors (NCT05746104) | Abramson Cancer Center at Penn Medicine | 2023-03-31 |
| A Study to Investigate Safety, Tolerability, and Pharmacokinetics of AZD7503 in Participants With Suspected NASH. (NCT05864391) | AstraZeneca | 2023-03-31 |
| SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma (NCT05568680) | Verismo Therapeutics | 2023-03-30 |
| A Phase 1 Study to Evaluate the Safety and Tolerability of TT-01488 in Patients With B-Cell Malignancies (NCT05683717) | TransThera Sciences (Nanjing), Inc. | 2023-03-30 |
| Safety and Effectiveness of ABM-168 in Adults with Advanced Solid Tumors. (NCT05831995) | ABM Therapeutics Corporation | 2023-03-30 |
| Phamacokinetics and Safety Profiles of DA-1229_01 5/1000mg in Healthy Subjects at Fed State (NCT05739916) | Dong-A ST Co., Ltd. | 2023-03-30 |